Nick Savasta is a Partner with Mercury Capital Advisors' Asset Management. He was previously Managing Director and Co-Head of the Strategic Investments Group at Michael Dell’s MSD Partners. Prior to that, Nick worked as a senior merchant banker with Allen & Company where he was a Director of the firm. He began his career as an investment banker in Morgan Stanley’s Corporate Finance Division. He is Chairman of the Board of Directors of MC2, a cyber-security Private Equity firm he co-founded with former United States Secretary of Homeland Security Michael Chertoff. Nick is a member of the Board of Overseers of Harvard University’s Beth Israel Deaconess Medical Center. He works closely with Harvard Medical School and is Co-Chairman of the Cancer Center Advisory Board at Beth Israel Deaconess Medical Center. Nick has served on the Executive Board of the MIT Sloan School of Management. He was previously a guest lecturer at Yale University, where he taught the school’s Introduction to Alternative Investments Seminar. He is a member of the Economic Club of New York and serves on The Contemporary Arts Council of The Museum of Modern Art. In 2018, Nick was appointed to The Wall Street Journal CEO Council. He was recently appointed to Fortune’s CEO Initiative. He earned a B.S. in International Affairs from the Georgetown University School of Foreign Service with honors and received his MBA from MIT. He was a Fulbright Scholar and a Truman Fellow. Nick is a Chartered Alternative Investment Analyst (CAIA) Charter Holder. He is fluent in French, Italian and Arabic.